
Amicus Therapeutics, Inc.
NASDAQ:FOLD
6.08 (USD) • At close May 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Amicus Therapeutics, Inc. |
Symbool | FOLD |
Munteenheid | USD |
Prijs | 6.08 |
Beurswaarde | 1,872,220,480 |
Dividendpercentage | 0% |
52-weken bereik | 5.82 - 12.65 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Bradley L. Campbell M.B.A. |
Website | https://amicusrx.com |
An error occurred while fetching data.
Over Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)